Frequently Asked Questions

Conference Speakers

Cultural Speakers

Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.

At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:

- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Dr. Second Speaker Name
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
View Registration Info
Speakers

Speakers (5191)

Sunday, 08 August 2021 11:18

Junpei Soeda

Written by
Sunday, 08 August 2021 11:18

Jin-Liern Hong

Written by
Sunday, 08 August 2021 11:18

Sabina Berezowska

Written by
Dr. Berezowska is an associate professor for pulmonary pathology at the University of Lausanne and a senior consultant pathologist at the Institute of Pathology of the Lausanne University Hospital (CHUV), Switzerland. She completed her residency at the Institutes of Pathology of the Ludwig Maximilians University in Munich (Germany) and University of Bern (Switzerland). In the following years as a full staff member at the Institute of Pathology of the University of Bern, she set her diagnostic and research focus on lung pathology, and consolidated her knowledge during a 3-months stay at the University of Michigan in Ann Arbor. Since 2014, she was in charge of thoracic pathology diagnostics and research in Bern, before moving to Lausanne.
Her research focuses on tissue based assessment of lung cancer including its brain metastases in the field of biomarker research, currently expanded by digital pathology approaches.
Dr. Berezowska is an active member of several international and national societies and serves currently as a member of the Pathology Committee of the IASLC.
Sunday, 08 August 2021 11:18

Benjamin Levy

Written by
Dr. Levy is Associate Professor at the Johns Hopkins School of Medicine and recently recruited to be Clinical Director of The Sidney Kimmel Cancer Center, Johns Hopkins Medicine at Sibley Hospital in Washington DC. Prior to his Hopkins appointment, Dr Levy was Medical Director of Thoracic Oncology Program for Mount Sinai Health Systems in New York City and Associate Director of the Cancer Clinical Trials Office (CCTO). Dr Levy is a physician scientist who is currently leading global immunotherapy trials evaluating checkpoint point inhibitors with novel combination strategies. In addition, he currently leads multiple targeted therapy trial with specific interest in EGFR mutations. Dr. Levy has played an integral role on several American Society of Clinical Oncology (ASCO) committees and currently serves as editor in chief for the ASCO Self Evaluation Program (SEP). He also serves on the Lungevity Scientific Advisory board as well as the IASLC’s International Lung Cancer Foundation Advisory Board. He is an ad hoc reviewer for Clinical Cancer Research (CCR), Annals of Oncology and the Journal of Clinical Oncology. He was recently selected as one of only 15 oncologist in the country to the prestigious ASCO Leadership Development Program whose mission is to identify and develop future leaders of ASCO.
Sunday, 08 August 2021 11:18

Lee A Albacker

Written by
Sunday, 08 August 2021 11:18

Don L Gibbons

Written by
Sunday, 08 August 2021 11:18

John V Heymach

Written by
Sunday, 08 August 2021 11:18

Jack Lee

Written by
Page 230 of 371